Endometriosis and Cannabis: What the Research Actually Says

Heating pad on the belly. Clock says 2:07. Someone already told you to wait it out.

Surveys say a lot of people with endometriosis reach for cannabis on nights like that. A real trial that tested CBD oil after surgery didn't beat a dummy oil. That gap is the whole story. This page sticks to the endometriosis research, not a PMS or period-cramp how-to. The wider map lives in our women's health cannabis pillar.

Surveys report that many people with endometriosis feel less pelvic pain, better sleep, and less nausea when they use cannabis. Those answers are self-report. Keep your doctor. Nobody has shown the plant shrinks lesions or replaces hormones or surgery.

Divine Toke is a Detroit-area Michigan shop. We grow sun-grown flower. We sell jars, 1g pre-rolls, and a 20-pack of those 1g joints. We don't sell a tincture, a cream, or an edible. Other licensed shops do. No milligram protocol from a farm blog.

What Does the Research Actually Say About Cannabis and Endometriosis Pain? #

Surveys report relief. The one finished placebo-controlled CBD-oil trial didn't beat placebo. Reviews still call the human evidence thin. If someone sells you "the science is settled," they're selling you a night, not a paper.

Here's the 2026 stack:

What you can quote	Design	What people reported	What it cannot carry
Sinclair 2020, JOGC, PMID 31722852	Australian online survey, 484 people with surgically confirmed endometriosis	Of those using self-management, 13% used cannabis. Pain-relief score 7.6 out of 10. 56% cut other meds by at least half.	Not a trial. People picked themselves.
Sinclair 2021, PLoS One, PMC8547625	App log, 252 people, 16,193 sessions	Inhale was 67.4% of sessions. Pain was the target in 57.3%. Gut symptoms improved the most in the model.	Self-reported endometriosis. No dummy jar.
German-speaking survey 2024, PMC11485029	Online survey, 912 valid answers	114 people (17%) used cannabis. Sleep 91%, period pain 90%, non-cycle pain 80% among users. About 90% said they cut pain pills.	Still a survey. Cannabis was mostly illicit there.
DREAMLAND 2026, PMID 42261989 / NCT05670353	Randomized, triple-blind, CBD-enriched oil vs placebo after surgery, 102 people. University of São Paulo registry. Not the Hershey trial.	About 40% in both groups hit a 50% pain drop. End pain 41.6 mm on CBD vs 36.8 mm on placebo. Trial stopped early.	CBD oil wasn't better than the dummy. More mild side effects on CBD.
Henry 2026, BMC Complement Med Ther, PMC12908271	Aotearoa NZ prospective cohort. 40 recruited. 10 early dropouts. 2 left after pregnancy. n=28 finished 12 weeks. No dummy arm.	Overall pelvic pain 5.46 → 3.77. Worst pain 7.62 → 5.38.	Observational. No placebo. Cannot outrun DREAMLAND.

The 2026 scoping review in Australian and New Zealand Journal of Obstetrics and Gynaecology (PMC12920050) went online first on 2025-12-09 (journal year 2026). It said the observational papers keep showing pain relief, and that high-quality trials were still missing when that review closed. DREAMLAND landed after that gap was already the headline.

Henry 2026 is a later observational pile, not a second placebo trial. Forty people in Aotearoa New Zealand started a first medicinal-cannabis prescription. Ten dropped out early. Two left after pregnancy. Twenty-eight finished 12 weeks. Overall pelvic pain moved 5.46 to 3.77. Those 28 people reported a real drop. The study still has no dummy jar, so it cannot outrun DREAMLAND (NCT05670353).

ACOG Clinical Consensus No. 7 (July 2024) is the U.S. gyn line you'll hear in a Detroit clinic: there aren't enough data to recommend cannabis products for gynecologic pain, including endometriosis-associated pain. Clinicians should still ask, because people are already using it.

The 2025 RANZCOG Australian Living Evidence endometriosis guideline says the same thing in different ink: clinicians should discuss medicinal and non-prescribed cannabis because people already use it, and they should not recommend a product. Evidence on benefit and harm is thin.

What holds up:

• People with endometriosis keep telling surveys the plant takes the edge off pelvic pain, sleep, and gut nights.
• Those surveys can't prove the plant caused the drop.
• One finished CBD-oil trial after surgery didn't beat placebo on pain.
• Lesion shrink is a mouse-and-dish story so far, not a human outcome.

If you only keep one line: the couch says it helps. The one clean CBD trial said maybe not. Talk to the person who already knows your month.

How to read a paper type without a degree:

1. Survey. People remember a night and tick boxes. Good for "what are people already doing." Bad for "does it work."
2. App log. Same people, more timestamps. Still no dummy jar.
3. Randomized trial. Some people get the real oil. Some get a dummy. Labels hidden. This is the design that can say "better than chance."
4. Review. Someone stacked the above and said the pile is thin.

Sinclair 2020 also said the biggest self-reported gains sat in sleep and nausea and vomiting, not only in belly pain. Side effects were uncommon in that form (10%) and called minor. Still a memory study. If your 2 a.m. is a vomit-and-pad night, it tells you what other people were chasing. A Detroit clinician should not write a script from it.

This isn't the same question as "does weed help period cramps." Period-only pain has its own papers. We keep that in menstrual cramp relief. Endometriosis can be cyclic pain, non-cycle pain, pain with sex, pain with a bowel movement, and fatigue that eats a shift. Mixing those piles is how marketing happens.

Who this page is for:

• Adults who already have an endometriosis diagnosis, or a clinician working that up.
• People in Detroit and across Michigan who got told "wait it out" and then found a jar.
• Anyone mixing a heating-pad night with a plan to drop a GnRH shot.

Who should stop and call a licensed person instead of finishing a farm blog:

• You're pregnant or chestfeeding.
• You're planning a pregnancy. Ask the clinician. The FDA, CDC, and ACOG pages we cite talk about pregnancy and lactation. They don't spell out a standalone "while trying" rule.
• New sudden one-sided weakness, fainting, fever, or pain that's a different shape than your usual flare.
• A job that drug-tests (plant, hospital badge, CDL).
• You want to stop a prescription tonight because a caption said so. Don't.

How endometriosis pain is not "just a bad period" #

A heating pad can fail on a Tuesday in October when you aren't even bleeding. Endometriosis is tissue like the uterine lining growing where it doesn't belong. Sinclair 2021 lists chronic pelvic pain, period pain, pain with sex, and gut pain in the same disease. This spoke stays off the cramp pile.

PMC10671947 puts the everyday pile in one sentence: lesions break down, swelling and scar tissue stack, and the belly stays loud. Hormones and surgery try to change that environment. Cannabis, in the human papers we have, is being asked to change how loud the night feels. Those are different jobs.

Metro Detroit makes the night messier. A 2 a.m. plant shift, a hospital stretch, or a winter week with no sun can sit on top of a flare. You can't read one calm Saturday as proof the jar is "working the disease."

Why Do Surveys Look Stronger Than the One Real Trial? #

Surveys ask people who already chose cannabis. A trial gives some people a dummy and hides the label. Those designs answer different questions. Both can be true at once. The jar can feel useful, and a measured CBD oil still failed to beat placebo after surgery.

Why the surveys look loud:

• People who hated the plant rarely finish a 40-minute form.
• Memory is kind to the night the pad finally cooled.
• Sinclair 2020 recruited through advocacy groups, not a random Michigan waiting room.
• PMC8547625 logged people who already opened a tracking app. Opening the app is already a vote.

What DREAMLAND actually tested, from the 2026 abstract (PMID 42261989) and registry NCT05670353:

1. Surgically confirmed endometriosis, already operated on, still flaring, already on hormones.
2. Oral CBD-enriched oil vs placebo, twice a day, 10 weeks, dose climbed from 10 mg/day to 150 mg/day, then a taper.
3. 102 people randomized, 51 per arm.
4. Pain in both groups dropped. The groups didn't separate.
5. The team stopped at the planned look because the benefit wasn't there and mild side effects were higher on CBD.

Hard sentence if you're on the couch. Still the only finished placebo result we can point at for a CBD oil in this disease. It doesn't test smoked flower, a THC-forward jar, or a Detroit adult-use pre-roll. Don't read it as "cannabis does nothing." Don't read the surveys as "cannabis is settled."

Open trials still in the registry, pulled from ClinicalTrials.gov:

Registry ID	What it is	Status as of the 2026-09-20 pull
NCT04527003	Milton S. Hershey Medical Center CBD extract plus norethindrone acetate vs placebo. Daily 0–100 pain scale (VAS). Primary endpoint is area-under-the-curve over 8 weeks. Not DREAMLAND.	Terminated (recruitment; live ClinicalTrials.gov pull 2026-09-20). Start 2020-12-04. Primary completion 2024-05-29. Study completion 2024-06-26. Results reported.
NCT06477406	McLean Hospital high-CBD sublingual product vs placebo for 12 weeks. Pain scores for period pain, pain with sex, and non-period pelvic pain.	Recruiting. Start 2024-02-27. Estimated completion June 30, 2026 on some mirrors; live ClinicalTrials.gov (updated 2026-07-17) lists 2026-10.

PMC12920050 already warned that upcoming CBD-only trials will leave THC-plus-CBD questions open. Mixed-product questions stay unanswered.

A dummy-controlled night is a different psychology than a night you chose. In DREAMLAND, people in both arms improved. The authors said that out loud: placebo is strong in pain, and their extra analyses didn't have the power to pretend otherwise. If your cousin swears by a tincture she bought on Woodward after a clinic visit, she can be right about her body and the trial can still be right about the average.

What a finished trial still doesn't close:

• Smoked or vaped flower in a flare.
• A THC-forward Michigan adult-use jar.
• People who haven't had surgery yet.
• People who can't take hormones.
• Long months of use, not ten weeks.

For a wider pain map that isn't endometriosis, see our cannabis for pain guide. For tiny daytime amounts that are about function, not a disease protocol, see microdosing.

Can Cannabis Shrink Endometriosis Lesions? #

No human trial has shown that cannabis shrinks endometriosis lesions. Lab and mouse work is interesting. Symptom relief is the only human story you can repeat without stretching. If a shop card says "kills endo," close the tab.

What tissue papers actually show:

• The endocannabinoid system (your body's own cannabis-like signals) shows up in uterine tissue and in lesions. PMC11353223 notes CB1 and CB2 (the two main cannabis locks in the body) in endometrial glands in people with endometriosis.
• PMC9184153 is a lesion-expression paper, not a treatment trial.
• PMC10671947 reviews a messy ECS in this disease: inflammation, pain signaling, and gut talk. It also cites mouse work where repeated THC slowed ectopic tissue. Mice aren't a Michigan clinic.

Plain words:

Claim you'll hear	What the papers support	Hedge
Cannabis calms the night	Surveys and app logs	Self-report, no dummy in those studies
Cannabis treats the disease	Not in humans	Preclinical only
CBD melts lesions	Not shown	Don't buy that caption
THC is a surgery alternative	Not shown	Surgery decisions stay with a gyn

PMC11353223 ends the way a careful review should: small samples, lots of observational work, need blinded trials. I'm not writing past that.

Think of the ECS like a thermostat that helps pain, swelling, and mood stay in range. Endometriosis looks, in tissue papers, like that thermostat is off. Giving the body extra plant cannabinoids might turn the dial on pain. Might is the word. Turning the dial isn't the same as removing the tissue a surgeon can see.

If a friend swears the jar "cleared her endo," ask what imaging or surgery showed. Feelings are real. Lesion load is a different measurement.

The ESHRE endometriosis guideline hub is the European society page clinicians still use for standard care. It's built around hormones, pain medicines, and surgery. Cannabis isn't sitting there as a recommended disease treatment. That absence matches ACOG's "not enough data" line, even if the two groups wrote different documents.

A Michigan shop can still sell you flower. A society guideline is a different kind of paper. Keep them in different pockets.

Is THC, CBD, or Both Better for Endometriosis Pain? #

Nobody has a winning ratio from a head-to-head endometriosis trial. Surveys lean toward mixed products. The finished oil trial was CBD-forward and lost to placebo. People reach for both in the logs. Shopping habit. Nobody ran a protocol from it.

What the papers pin:

• PMC8547625 found the THC-to-CBD ratio had a statistically real but clinically small effect that changed with the route. For oral products, more CBD relative to THC looked a bit better in that model. For inhale, the ratio story was weaker. The authors still asked for trials.
• ACOG 2024 cites a small office survey (113 people with chronic pelvic pain): among cannabis users, a mix of CBD and THC was the most common pick, and those people reported the most improvement. Twenty-six users talking. Nobody ranked the molecules.
• DREAMLAND used a CBD-enriched oil. It didn't beat placebo on pain. Psychological scores and some quality-of-life domains moved more on CBD, but physical quality-of-life scores favored placebo. Call it mixed.
• PMC12920050 notes most observational endo papers used products with both THC and CBD, and that CBD-only trials won't close the class.

THC is the cannabinoid that gets you high. CBD is the one that doesn't. Both talk to the same wider system. For migraine abort, a 2026 flower trial found THC plus CBD beat CBD-only. Migraine is a different disease. We keep that split in migraine prevention vs abort. Don't steal that result for your ovary.

Shopping notes:

• A CBD-only bottle isn't "the endometriosis one." DREAMLAND already tested an oil lane and didn't win on pain.
• A heavy THC jar can wreck a day shift. Endometriosis already wrecks shifts.
• Michigan adult-use labels list THC and CBD. Read the number. Don't chase a secret ratio you saw on a forum.

Divine Toke does not invent a chemotype as a treatment. If you smell a jar, you're shopping flower. Nobody is filling a prescription at the counter.

Blueberry Mojito, Honey Bananas, and L.A. Sunshine are the names on our jars when those lots are up. They're not endometriosis strains. A mango-leaning nose or a citrus nose doesn't map to a lesion. If a budtender in another shop promises a cultivar as pelvic medicine, that's marketing. Walk.

Flower, Oils, and Topicals: What Did People Actually Use? #

In the endometriosis logs, people mostly inhaled. Oral oils showed up next. Topicals were rare. A 2024 CBD vaginal study was for menstrual pain, not endometriosis. Fast onset is why a joint shows up at 2 a.m. Slow onset is why an oil is a different clock.

From PMC8547625:

Route in the app log	Share of sessions	What the authors said
Inhaled (vape, smoke, a little concentrate)	67.4%	Favored. Fast onset (often 5 to 10 minutes in the pharmacology they cite). No pain-score gap vs oral at the app's check-in times.
Oral (oils, pills, edibles, tincture/spray)	32.3%	Looked better for mood and gut in the model. Check-in was later (about 90 minutes).
Topical / transdermal	0.3% combined	Tiny n. The model gave topicals a high efficacy bump, but 53 sessions isn't a product line.

Sinclair 2021 also notes Australian and New Zealand illicit surveys favored inhale (about 62% and 68% in those older papers). Legal menus didn't erase the inhale habit. Speed is a better explanation than "they had no other choice."

PMC11485029 saw smoking as the most common method among 114 users (106 named it), with vape, edibles, and "other" also in the mix. Frequency ran from several times a day to once a week. No milligram lives in that spread.

The 2024 npj Women's Health high-CBD vaginal study is the paper people paste into endometriosis threads. Read the title. It's menstrual-related pain, not endometriosis. We already flagged that split in the cramp spoke. Don't borrow it.

What other shops sell:

• Tinctures and oils (under the tongue or swallowed). Slower. Easier to repeat a small amount if the label is honest.
• Topicals and balms. Skin-deep. A deep pelvic lesion isn't a wrist sprain.
• Vaginal or rectal products. Biologically interesting. Endometriosis-specific trial evidence is thin.
• Flower and joints. Fast. Impairing if the THC is high. This is the Divine Toke lane.

We sell sun-grown flower, 1g joints, and a 20-pack of 20 × 1g. No Divine Toke "endo cream." No gummy. A 1g joint is a known size if you're trying to keep a night small. A 20-pack is for people who already know the jar, not a dare to smoke through a flare week.

A Michigan COA won't say "for endometriosis." It'll say cannabinoids, sometimes terpenes, and the pass/fail safety panel the Michigan CRA requires on licensed flower. Read that sheet like a grocery label. If the terp line is empty, you're shopping a number, not a smell. Nose first, then the paper. Use both when you shop. Skip treating the sheet as a dose.

Hormone talk and cycle timing live in women and cannabis hormones. This page leaves estrogen to that spoke.

Is Endometriosis a Michigan Medical Marijuana Qualifying Condition? #

No. Endometriosis isn't named on the Michigan list. Chronic pain is. Severe and chronic pain is. Severe nausea is. A Detroit-area clinician can still certify you if your case fits a named lane. Adults 21+ can also buy adult-use without a card.

The official list is the Michigan CRA eligible-conditions FAQ. Pulled when we wrote this. You'll see cancer, Crohn's, PTSD, arthritis, chronic pain, and a catch-all for a disease or its treatment that produces severe and chronic pain, severe nausea, seizures, or severe muscle spasms. You won't see the word endometriosis.

What that means in a Michigan week:

• A medical-card visit is a real appointment with a physician who already has a bona fide relationship with you, or who will build one. Don't invent a clinic name from a blog.
• Metro Detroit has plenty of those offices. The card is state paper, not a Divine Toke product.
• Adult-use at 21+ is the other door under MCL 333.27955. Different tax, different daily limits, same plant chemistry.
• A card doesn't make the research thicker. It changes how you buy.
• Bring a list: hormones, pain pills, antidepressants, blood thinners, anything the liver already handles. A Detroit clinic can't guess your drawer from a flare face.

The catch-all line on the CRA page matters more than the missing word. If endometriosis (or its treatment) is producing severe and chronic pain or severe nausea, that's the statutory door many clinicians use. "Named" and "certifiable" aren't the same sentence. Only the physician writes the second one.

Adult-use is still legal cannabis in Michigan if you're 21+. You don't need a pelvic diagnosis to buy a jar. You also don't get a medical defense at work, or a pass on a roadside stop, just because the night was bad.

ACOG 2024 wants clinicians to ask about cannabis without punishment. That matters in Detroit as much as it matters in any city that still treats the plant like a character test. Bring the list of what you already take. Bring the nights that drop you. Don't ask a budtender to be your gyn.

A useful Detroit-clinic script, if you want one:

• "I have endometriosis. I've been using cannabis some nights. I'm not asking you to bless it as a cure."
• "Here's what I take already. Here's what the flare does to work."
• "Tell me if my path is chronic pain on the medical card, or adult-use as the cleaner door."
• "I won't drop the hormone unless you say so."

Bring those lines to clinic. A farm blog doesn't write your protocol.

If you're shopping adult-use flower in Michigan, the label and the COA (the lab sheet) are the receipts. We'll talk terps and size. A clerk doesn't have an "endometriosis one."

What About Fertility, Pregnancy, Hormones, and Pain Pills? #

Major U.S. agencies say don't use cannabis, including CBD, if you're pregnant or breastfeeding. Fertility, GnRH shots, and NSAID stacking are mostly unstudied together. Don't drop a medicine because a farm site sounded kind.

Pinned sources:

• FDA consumer update on cannabis and CBD in pregnancy
• CDC cannabis and pregnancy
• ACOG 2025 consensus on cannabis in pregnancy and lactation

What is known enough to say out loud:

Topic	What we can say	What we can't say
Pregnancy / chestfeeding	FDA, CDC, and ACOG say avoid cannabis and CBD in any form.	A "low CBD is fine" dose.
Planning a pregnancy	FDA, CDC, and ACOG 2025 write pregnancy and lactation. They do not write a standalone "while trying" rule. Human fertility data are limited. Ask the clinician before that month.	That a joint will or won't block a cycle.
Hormonal birth control	No solid endometriosis paper proves the pill stops working. CBD can bother liver enzymes. That's a clinician question.	A green light to mix without asking.
GnRH agonists / antagonists	No direct cannabis trial in that pair. Unknown.	A swap list.
NSAIDs (ibuprofen and kin)	No endometriosis-specific stacking trial. Gut and kidney risk already live with NSAIDs.	That the combo is proven safe or proven dangerous.
Opioids	Sinclair 2020 and PMC11485029 report people cutting pills. ACOG 2024 calls that low-quality survey signal and says more data are needed before anyone substitutes.	"Trade your norco for a joint" as advice.
Surgery recovery	DREAMLAND was after surgery, on hormones, testing CBD oil for recurrent pain. It didn't beat placebo. Nobody should treat it as a recovery protocol.	That flower helps you heal faster.

PMC10671947 notes people with endometriosis already carry a higher risk of long-term opioid use than people without it, and that opioids are a poor fit for chronic pelvic pain. Stay in a doctor's office for that risk. A caption still cannot replace the visit.

CBD can raise liver enzymes at higher exposures. If you already take something the liver processes, say that out loud at the visit. We don't guess your panel.

The small office survey inside ACOG 2024 is worth a second look for side effects, not for hope. Among 26 cannabis users with chronic pelvic pain, 84% reported at least one adverse effect: dry mouth, sleepiness, feeling high. Nearly one-third said they cut opioids. ACOG still called the opioid-sparing signal low-quality and said it's too early to substitute. Both facts can sit in one paragraph.

Impairment is real. A Michigan road, a machine shop, or a night drive after a heavy inhale isn't a research debate. If you can't drive after a pain pill, you can't drive after a strong joint either.

Adolescents are a separate risk pile. ACOG says young brains carry extra cognitive and psychosis risk, and that data aren't good enough to recommend cannabis products for gynecologic pain in that age group. This shop page is for adults. If the person on the couch is 16, this isn't their article.

What Cannabis Cannot Replace for Endometriosis #

It can't diagnose you, remove lesions, restart a failed hormone, or stand in for imaging. It also can't make a caption into a care plan. The plant might take the edge off a night. The disease still needs a clinician.

Things the papers don't let us promise:

• A shorter time to diagnosis. PMC11485029 still saw about 9 years from first symptoms to diagnosis in that European survey. A jar doesn't shorten that.
• Fertility rescue. If you're building a family, that conversation is gyn and, if needed, a fertility clinic. Not a pre-roll.
• A skip past laparoscopy or excision when those are on the table.
• A clean workplace drug test. Michigan legal doesn't equal employer-legal.

Things you can do that aren't magic:

1. Keep the heating pad, the bowel routine, and the meds you already agreed to.
2. Write the nights down: cycle day, pain 0 to 10, what you used, whether you could work. Patterns beat vibes.
3. Tell the clinician you used cannabis. ACOG asked them to hear it.
4. If you try Michigan flower, start smaller than your pride wants. Fast inhale is easy to overshoot at 2 a.m.
5. If a night is a different pain than your usual, that's a clinic or an ER, not a bigger joint.

Common ways this topic goes sideways:

• Treating a period-cramp paper as an endometriosis paper. Different disease, different nerves.
• Treating a mouse lesion study as a human cure.
• Treating a cousin's good night as a protocol.
• Treating a Michigan card as proof the plant works.
• Treating a 1g joint as a hormone taper.

If you need a notebook more than a vibe, the habit is the same as any other pain log: date, cycle day, 0-to-10, what you swallowed or smoked, whether you made the shift. No printable chart from this farm blog. The pain guide is the wider pain map if endometriosis is only one of the things in your month.

Divine Toke is Detroit-rooted and Michigan-grown. We'll smell a jar with you. Sun-grown soil is not pelvic surgery.

FAQ #

Q: What does the research actually say about cannabis and endometriosis pain? #

Surveys report a lot of relief. The one finished CBD-oil trial didn't beat placebo. Sinclair 2020 and PMC8547625 are the survey and app logs people quote. DREAMLAND 2026 is the placebo sentence. ACOG 2024 still won't recommend cannabis for gynecologic pain. Not a substitute for a doctor.

Q: Does CBD help endometriosis? #

Not as a proven pain treatment. A CBD-enriched oil failed to beat placebo after surgery in DREAMLAND. PMID 42261989 randomized 102 people. Both groups improved. The groups didn't separate. More mild side effects sat on the CBD side. CBD-only as a secret key is a caption, not that trial.

Q: Does THC work better than CBD for endometriosis? #

Unknown in a head-to-head endometriosis trial. PMC8547625 saw only a small ratio effect that changed by route. ACOG noted mixed CBD-plus-THC products in a tiny office sample. Don't import a migraine flower result into this disease.

Q: Can cannabis shrink endometriosis lesions? #

No human evidence that it does. PMC11353223 and PMC10671947 keep lesion-growth findings in animals and dishes. Symptom relief is the human lane. Disease modification isn't.

Q: Is endometriosis a qualifying condition for a Michigan medical marijuana card? #

It's not named. Chronic pain and severe nausea are. See the CRA list. A physician decides if your case fits. Adults 21+ can use the adult-use door without a card.

Q: Should I stop my hormone, GnRH shot, or pain medicine if I try cannabis? #

No. This page won't tell you to drop a medicine. ACOG 2024 says more data are needed before anyone treats cannabis as a substitute. Surveys that show people cutting pills aren't a taper plan.

Q: Are topicals or tinctures better than flower for endometriosis? #

The logs say people mostly inhale. Topicals were rare. Tinctures sit in the oral pile. PMC8547625 is the session breakdown. Divine Toke doesn't sell a topical or a tincture. Other Michigan shops do. The 2024 vaginal CBD paper is a period-pain study, not an endo trial (npj Women's Health).

Q: Is cannabis safe if I am trying to get pregnant? #

FDA, CDC, and ACOG 2025 say avoid cannabis, including CBD, during pregnancy and while breastfeeding. They don't write a clean standalone "while trying" rule. Fertility data are limited. Ask the clinician before that month. FDA, CDC, and ACOG 2025 are the pages. "Low CBD" isn't a loophole they wrote.

Q: Why did my friend get so much relief if the trial failed? #

Surveys and placebos both move pain scores. DREAMLAND showed the dummy oil moved them too. About 40% of people in both arms hit a 50% pain drop in PMID 42261989. Your friend can be telling the truth about her night. That still doesn't make a protocol.

Q: How common is cannabis use among people with endometriosis? #

Common enough that ACOG wrote a consensus. Not a majority in the clinic registry they cite. ACOG 2024 reports 402 of 2,663 people with endometriosis (15%) in one referral registry. The 2024 German-speaking survey found 114 of 912 (17%). Different countries, different laws, same ballpark.

Q: What does Divine Toke sell if I want a small, repeatable amount? #

Sun-grown flower, 1g pre-rolls, and a 20-pack of those 1g joints. Those three. No gummy. No cream. No half-gram listing. Start at the shop. Ask for the COA. No endometriosis milligram from us.

Q: Where should I start if I want the wider women's-health map? #

The PMS-to-menopause pillar, then the hormones spoke if the cycle is the question. Period-only product timing is the cramp spoke. This page stays on endometriosis papers.

---

If you already live on the heating pad, the survey night and the trial night aren't the same story.

Use the women's health pillar for the wider map. Use the pain guide if the question is pain in general. Use microdosing if you're trying to stay functional at work.

If you're curious to try Michigan sun-grown flower from a Detroit-rooted shop, we have jars, 1g joints, and the 20-pack. Smell first. Keep the gynecologist in the loop. The heating pad can stay. The trial can stay honest.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any new wellness routine.